This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Universitätsklinikum Freiburg, Albert-Ludwigs-Universitaet Freiburg, Universitaetsklinikum Freiburg. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 36 
1 out of 47 
1 out of 40 Years Active: 2012-2025
Title: Innovations of Philipp Wolf in Cancer Treatment
Introduction
Philipp Wolf is an accomplished inventor based in Gundelfingen, Germany. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 4 patents, his work focuses on developing advanced therapeutic methods targeting prostate cancer.
Latest Patents
Wolf's latest patents include groundbreaking inventions such as chimeric antigen receptors that bind to prostate-specific membrane antigen (PSMA). This invention relates to a novel chimeric antigen receptor (CAR) that comprises an antigen-binding fragment specifically targeting PSMA. The method of manufacturing high-quality CAR T cell products allows for effective in vivo tumor treatment, either alone or in combination with various pharmaceutical drugs, including chemotherapies and biopharmaceuticals. Another notable patent involves monoclonal antibodies and single-chain antibody fragments against cell-surface PSMA. These isolated monoclonal antibodies bind to PSMA in its native form on tumor cells and can be linked to a label or cytotoxic agent, or constructed as part of a bispecific antibody or recombinant diabody.
Career Highlights
Throughout his career, Philipp Wolf has worked with prestigious institutions, including Universitätsklinikum Freiburg and Universitätsklinikum Freiburg. His research and innovations have significantly advanced the understanding and treatment of prostate cancer.
Collaborations
Wolf has collaborated with notable colleagues, including Ursula Elsässer-Beile and Dorothee Gierschner. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Philipp Wolf's contributions to cancer treatment through his patents demonstrate his commitment to advancing medical science. His innovative approaches to targeting prostate cancer have the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile